際際滷

際際滷Share a Scribd company logo
Expanded Dengue Syndrome
Simplified!!!
Medicine & Science is advancing..
Diseases / Bugs are also
advancing.
Evolution is bound to happen.
Doctor
Disease
The bugs will change and we need to change too
Survival of the fittest
2022 Dengue EXPANDED.pptx
2009
EDS was not
defined in
2009 also
Dengue Fever - Classification
EDS
Defined in
2011
Dengue Fever - Classification
1997 -2009 : WHO : No mention of EDS
2011 : WHO : EDS is defined
India 2014
EDS Definition : WHO
Unusual manifestations of patients with severe organ (single / multiple organ) involvement
such as liver, kidneys, brain or heart associated with dengue infection(WHO 2011), which are
not usually explained by dengue fever or dengue hemorrhagic fever.
They could be associated with underlying host conditions (Infants, DM etc) or co-infections
(Malaria, typhoid etc) or as a complication of profound shock.
Kadam DB, Salvi S, Chandanwale A. Expanded Dengue. J Assoc Physicians India. 2016 Jul;64(7):59-63.
Umakanth M, Suganthan N. Unusual manifestations of dengue fever: a review on expanded dengue
syndrome. Cureus 2020;12:e10678
2022 Dengue EXPANDED.pptx
2022 Dengue EXPANDED.pptx
Dengue Expanded Syndrome is
Under recognized &
Under reported
Expanded Dengue Syndrome is not about fluids
But about severe organ dysfunction
Including
Dengue Liver Failure
Dengue ARDS
Dengue MODS
Including
Dengue HLH
Dengue Encephalitis
Dengue AKI
Dengue Expanded Syndrome
Treatment is
Organ specific &
Organ supportive
Name Dr Maninder Singh Dhaliwal
Qualification MD Paeds, DAA,
Fellowship Ped Critical Care 2010
Designation Senior Consultant
PICU & Ped Pulmonology
Institution Amrita Hospital, Faridabad
Thank You
Lets Win Against Dengue

More Related Content

2022 Dengue EXPANDED.pptx

  • 2. Medicine & Science is advancing.. Diseases / Bugs are also advancing.
  • 3. Evolution is bound to happen. Doctor Disease The bugs will change and we need to change too Survival of the fittest
  • 6. Dengue Fever - Classification EDS Defined in 2011
  • 7. Dengue Fever - Classification
  • 8. 1997 -2009 : WHO : No mention of EDS
  • 9. 2011 : WHO : EDS is defined
  • 11. EDS Definition : WHO Unusual manifestations of patients with severe organ (single / multiple organ) involvement such as liver, kidneys, brain or heart associated with dengue infection(WHO 2011), which are not usually explained by dengue fever or dengue hemorrhagic fever. They could be associated with underlying host conditions (Infants, DM etc) or co-infections (Malaria, typhoid etc) or as a complication of profound shock. Kadam DB, Salvi S, Chandanwale A. Expanded Dengue. J Assoc Physicians India. 2016 Jul;64(7):59-63. Umakanth M, Suganthan N. Unusual manifestations of dengue fever: a review on expanded dengue syndrome. Cureus 2020;12:e10678
  • 14. Dengue Expanded Syndrome is Under recognized & Under reported
  • 15. Expanded Dengue Syndrome is not about fluids But about severe organ dysfunction Including Dengue Liver Failure Dengue ARDS Dengue MODS Including Dengue HLH Dengue Encephalitis Dengue AKI
  • 16. Dengue Expanded Syndrome Treatment is Organ specific & Organ supportive
  • 17. Name Dr Maninder Singh Dhaliwal Qualification MD Paeds, DAA, Fellowship Ped Critical Care 2010 Designation Senior Consultant PICU & Ped Pulmonology Institution Amrita Hospital, Faridabad Thank You Lets Win Against Dengue

Editor's Notes

  1. the classifi cation into levels of severity has a high potential for being of practical use in the clinicians decision as to where and how intensively the patient should be observed and treated (i.e. triage, which is particularly useful in outbreaks), in more consistent reporting in the national and international surveillance system, and as an end-point measure in dengue vaccine and drug trials.
  2. the classifi cation into levels of severity has a high potential for being of practical use in the clinicians decision as to where and how intensively the patient should be observed and treated (i.e. triage, which is particularly useful in outbreaks), in more consistent reporting in the national and international surveillance system, and as an end-point measure in dengue vaccine and drug trials.